Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety and Efficacy of Obatoclax Mesylate (GX15-070MS) in the Treatment of Hodgkin's Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00359892
Recruitment Status : Completed
First Posted : August 3, 2006
Last Update Posted : August 6, 2012
Sponsor:
Information provided by (Responsible Party):
Teva Pharmaceutical Industries ( Gemin X )

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : September 2007
Actual Study Completion Date : November 2008